Gene: FAM81A
Official Full Name: family with sequence similarity 81 member Aprovided by HGNC
Gene Summary: Predicted to enable molecular condensate scaffold activity. Predicted to be located in postsynaptic density. Predicted to be active in glutamatergic synapse and postsynaptic density, intracellular component. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24035 | FAM81A Knockout cell line (HeLa) | Human | FAM81A | 1:3~1:6 | Negative | Online Inquiry |
KO24036 | FAM81A Knockout cell line (HCT 116) | Human | FAM81A | 1:2~1:4 | Negative | Online Inquiry |
KO24037 | FAM81A Knockout cell line (HEK293) | Human | FAM81A | 1:3~1:6 | Negative | Online Inquiry |
KO24038 | FAM81A Knockout cell line (A549) | Human | FAM81A | 1:3~1:4 | Negative | Online Inquiry |
FAM81A Gene Knockout Cell Lines are genetically modified cellular models that have undergone targeted disruption of the FAM81A gene, known to play a crucial role in cellular signaling pathways and cancer biology. These cell lines are invaluable tools for researchers investigating the functional implications of FAM81A in both normal physiology and various disease states, particularly in cancer research.
The primary function of FAM81A involves its participation in cellular processes such as proliferation, differentiation, and apoptosis. The knockout of this gene allows for the examination of the downstream effects of its absence, including alterations in cellular signaling cascades and gene expression profiles, thus providing insight into the molecular mechanisms underlying specific pathologies. This powerful feature positions the FAM81A gene knockout cell lines as essential models for translational research, enabling the study of gene function and the evaluation of potential therapeutic targets.
The scientific importance of these cell lines extends to their applications in pharmacological testing and biomarker discovery, offering researchers a platform to assess the efficacy of novel treatments and understand how FAM81A contributes to drug resistance in tumor cells. Compared to traditional wild-type models, FAM81A knockout lines present a unique advantage as they allow for a clearer understanding of gene-specific roles, thereby streamlining research efforts.
Moreover, these cell lines empower researchers and clinicians by providing a highly relevant biological context in which to perform experiments, ensuring that findings are aligned with in vivo conditions. Investing in FAM81A Gene Knockout Cell Lines leads to more informed hypotheses and enhanced data reproducibility, crucial factors for successful research outcomes.
Our company specializes in the development of high-quality biological products, ensuring researchers have access to state-of-the-art tools that meet rigorous scientific standards. By choosing FAM81A Gene Knockout Cell Lines, you align yourself with a partner committed to advancing scientific discoveries through precision and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.